Recent Finacing
Recent Raise
Pahr Therapeutics is a clinical-stage biopharma developing mechanism-based therapies for pulmonary arterial hypertension, translating NCVC-derived research into candidate programs entering early clinical studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
